Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions highlight the comparative aspects of nasal high-flow therapy and non-invasive ventilation, with posts describing the study as a 'major trial' and noting that nasal high-flow was better tolerated by patients. Tone and word choices like 'potential alternative' and 'interesting findings' reflect a recognition of the therapy's promising role, suggesting a consensus that while the study is relevant and notable, its clinical impact is viewed as evolving rather than definitive.
Most discussions recognize the study's findings, especially the benefits of nasal high-flow therapy's tolerability and its comparison to NIV, indicating general support without deep skepticism.
Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To access the manuscript: https://t.co/FhSzF5jcy8
Don't miss the editorial on Nasal high‐flow therapy: Established roles and emerging opportunities discussed in #Respirology https://t.co/SvSXo7PWMb related to https://t.co/kPa73XTAlj and https://t.co/yKelFjLWS5
Nasal high‐flow therapy compared with non‐invasive ventilation in #COPD patients with chronic respiratory failure - A new randomized controlled cross‐over trial reported in #Respirology https://t.co/pBmOayh1AK
Check out Dr Steven McKinstry presenting a quick summary of our latest publication in @RespirologyAPSR, which compared Non-invasive ventilation (NIV) against a possible future alternative strategy of Nasal High-Flow Oxygen (NHF) for #COPD: https://t.co/Pf2RxrcuQE https://t.co/tnw5HqkJRs
Don't miss the latest Editor in Chief selection with FREE access in the November issue 24.11 available online now https://t.co/lhljdM7x8n & https://t.co/sb6rBCsIMY https://t.co/WgKPc76ph2
RESPIRATORY UPDATES "Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias." Details: https://t.co/d4DZENFbcl @APSRapsr @RespirologyAPSR #lung #respiratory #COPD #TB #lungcancer #asthma #2019nC0V https://t.co/A2RUhtfsIl
A randomized crossover trial comparing nasal high-flow therapy and noninvasive ventilation in COPD patients. While NIV reduces CO2 levels more effectively, NHF offers better tolerance and comfort, suggesting it as a…
RT @APSRapsr: RESPIRATORY UPDATES "Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias." Details: http…
RESPIRATORY UPDATES "Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias." Details: https://t.co/d4DZENFbcl @APSRapsr @RespirologyAPSR #lung #respiratory #COPD #TB #lungcancer #asthma #2019nC0V https://t.co/A2RUhtfsIl
RT @APSRapsr: "Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomiz…
RT @APSRapsr: "Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomiz…
"Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross‐over trial" Details : https://t.co/A2RUhtfsIl @APSRapsr @RespirologyAPSR #lung #respiratory #COPD #TB #lungcancer #asthma #2019nC0V
RT @APSRapsr: Respiratory Updates"Nasal high-flow therapy compared with non-invasive ventilation in #COPD patients with chronic #respirator…
Respiratory Updates"Nasal high-flow therapy compared with non-invasive ventilation in #COPD patients with chronic #respiratory failure: A randomized controlled crossover trial" https://t.co/iWRyslQWkO @APSRapsr @RespirologyAPSR #lung #pulmonary
Don't miss the latest Editor in Chief selection with FREE access in the November issue 24.11 available online now https://t.co/lhljdM7x8n & https://t.co/sb6rBCsIMY https://t.co/ZejiKO755m
Don't miss the latest Editor in Chief selection with FREE access in the November issue 24.11 available online now https://t.co/lhljdM7x8n & https://t.co/sb6rBCsIMY https://t.co/WgKPc76ph2
RT @RespirologyAPSR: Don't miss the editorial on Nasal high‐flow therapy: Established roles and emerging opportunities discussed in #Respir…
RT @RespirologyAPSR: Don't miss the editorial on Nasal high‐flow therapy: Established roles and emerging opportunities discussed in #Respir…
RT @RespirologyAPSR: Don't miss the editorial on Nasal high‐flow therapy: Established roles and emerging opportunities discussed in #Respir…
Don't miss the editorial on Nasal high‐flow therapy: Established roles and emerging opportunities discussed in #Respirology https://t.co/SvSXo7PWMb related to https://t.co/kPa73XTAlj and https://t.co/yKelFjLWS5
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @ClinResearchNZ: Check out Dr Steven McKinstry presenting a quick summary of our latest publication in @RespirologyAPSR, which compared…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @ClinResearchNZ: Check out Dr Steven McKinstry presenting a quick summary of our latest publication in @RespirologyAPSR, which compared…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @ClinResearchNZ: Check out Dr Steven McKinstry presenting a quick summary of our latest publication in @RespirologyAPSR, which compared…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
RT @RespirologyAPSR: Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To a…
Check out Dr Steven McKinstry presenting a quick summary of our latest publication in @RespirologyAPSR, which compared Non-invasive ventilation (NIV) against a possible future alternative strategy of Nasal High-Flow Oxygen (NHF) for #COPD: https://t.co/Pf2RxrcuQE https://t.co/tnw5HqkJRs
Nasal high‐flow therapy versus NIV in COPD patients with chronic respira... https://t.co/zsR4yfZiPR via @YouTube. To access the manuscript: https://t.co/FhSzF5jcy8
Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial.: Related Articles Nasal high-flow therapy compared with non-invasive ventilation in COPD… https://t.co/oscX9bL1s6 FOAMed
RT @RespirologyAPSR: Nasal high‐flow therapy compared with non‐invasive ventilation in #COPD patients with chronic respiratory failure - A…
Nasal high‐flow therapy compared with non‐invasive ventilation in #COPD patients with chronic respiratory failure - A new randomized controlled cross‐over trial reported in #Respirology https://t.co/pBmOayh1AK
RT @jamesfingleton: Great to have this paper in respirology, it can be found here: https://t.co/Jh1jIO8KQm First author is Steve Mckinstry…
RT @jamesfingleton: Great to have this paper in respirology, it can be found here: https://t.co/Jh1jIO8KQm First author is Steve Mckinstry…
R
AR
CR
A
HH
F
HC
N
LB
MZ